| Dr Fady Ghali, MD | |
|
789 Howard Avenue, Fmp 302, New Haven, CT 06519 | |
| (203) 785-5339 | |
| Not Available |
| Full Name | Dr Fady Ghali |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 8 Years |
| Location | 789 Howard Avenue, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992156640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD61151828 (Washington) | Secondary |
| 208800000X | Urology | 74555 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
The ratings agency Standard & Poor's has joined the chorus of concern about how the looming age wave will affect governments that must pay for escalating entitlement programs, The Wall Street Journal reports.
Although levodopa remains the "gold standard" to effectively control motor deficits in the treatment of early stage Parkinson's disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment with oral medications for Parkinson's disease, about 40% of patients experience lack of muscle control (dyskinesias), end-of-dose wearing off, and fluctuations in "On/Off" states.
Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.
A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC).The cost effectiveness analysis concluded that CTC or virtual colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy
The New York Times reports that the White House is encouraging skeptical state officials to expand Medicaid by using federal money to subsidize the purchase of private insurance for low-income people - a model not envisioned by drafters of the law.
› Verified 1 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
The ratings agency Standard & Poor's has joined the chorus of concern about how the looming age wave will affect governments that must pay for escalating entitlement programs, The Wall Street Journal reports.
Although levodopa remains the "gold standard" to effectively control motor deficits in the treatment of early stage Parkinson's disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment with oral medications for Parkinson's disease, about 40% of patients experience lack of muscle control (dyskinesias), end-of-dose wearing off, and fluctuations in "On/Off" states.
Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.
A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC).The cost effectiveness analysis concluded that CTC or virtual colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy
The New York Times reports that the White House is encouraging skeptical state officials to expand Medicaid by using federal money to subsidize the purchase of private insurance for low-income people - a model not envisioned by drafters of the law.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fady Ghali, MD Po Box 50095, Seattle, WA 98145-5090 Ph: () - | Dr Fady Ghali, MD 789 Howard Avenue, Fmp 302, New Haven, CT 06519 Ph: (203) 785-5339 |
News Archive
The ratings agency Standard & Poor's has joined the chorus of concern about how the looming age wave will affect governments that must pay for escalating entitlement programs, The Wall Street Journal reports.
Although levodopa remains the "gold standard" to effectively control motor deficits in the treatment of early stage Parkinson's disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment with oral medications for Parkinson's disease, about 40% of patients experience lack of muscle control (dyskinesias), end-of-dose wearing off, and fluctuations in "On/Off" states.
Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.
A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC).The cost effectiveness analysis concluded that CTC or virtual colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy
The New York Times reports that the White House is encouraging skeptical state officials to expand Medicaid by using federal money to subsidize the purchase of private insurance for low-income people - a model not envisioned by drafters of the law.
› Verified 1 days ago
Dr. Thomas V. Martin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 330 Orchard St, Suite 164, New Haven, CT 06511 Phone: 203-789-2222 Fax: 203-624-3697 | |
John W Colberg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building 3rd Floor, New Haven, CT 06519 Phone: 203-785-2815 Fax: 203-785-4043 | |
Harris E Foster Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Avenue #318, New Haven, CT 06520 Phone: 203-785-2815 Fax: 203-785-4043 | |
Dr. Gregory Lamont Lacy Ii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, New Haven, CT 06519 Phone: 203-785-2815 Fax: 203-785-4043 | |
Michael Howard Siev, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Ralph J Devito, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 330 Orchard St, Suite 164, New Haven, CT 06511 Phone: 203-789-2222 Fax: 203-624-3697 | |
Dr. Israel Franco, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 789 Howard Avenue,, Fmp 300, New Haven, CT 06520 Phone: 203-785-7671 |